LUMO   $4.32  -0.23% Market Closed

Lumos Pharma Inc
Total Cash 16.80M
totalCashPerShare 2.068
EBITDA -37.59M
Total Debt 449.00K
quickRatio 3.438
currentRatio 4.233
Total Revenue 1.49M
debtToEquity 4.37
Revenue/Share 0.184
ROA -0.60501
ROE -1.32561
grossProfits
freeCashflow -22.13M
operatingCashflow -34.49M
earningsGrowth
revenueGrowth -0.074
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -16.030739
profitMargins 0.0
enterpriseValue 19.31M
forwardPE -1.9770641
floatShares 5.32M
sharesOutstanding 8.65M
sharesShort 285.41K
sharesShortPriorMonth 315.95K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.33%
heldPercentInstitutions 0.28%
Short Ratio help_outline 10.16%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 1.265
Price To Book help_outline 3.41
earningsQuarterlyGrowth
netIncomeToCommon -35.75M
trailingEps -4.42%
forwardEps -2.18%
enterpriseToEbitda -0.51
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.76 3Q 2024
institutionsCount 38
lastUpdated Nov. 7, 2024, 3:13 a.m.